August 10, 2024

The FDA has re­ject­ed Lykos’ MD­MA-as­sist­ed treat­ment for pa­tients with post-trau­mat­ic stress dis­or­der, a ma­jor set­back for the com­pa­ny that had hoped to trans­late more

The fed­er­al gov­ern­ment has de­feat­ed an­oth­er law­suit against the In­fla­tion Re­duc­tion Act, this time brought by the US Cham­ber of Com­merce. An Ohio fed­er­al judge

With op­er­a­tions be­gin­ning in the fourth quar­ter, Am­gen said Fri­day that it is open­ing a new site in Hy­der­abad, In­dia, with 3,000 em­ploy­ees. Dubbed a

Over the last 40 years, twin packs of EpiPens be­came a fix­ture for peo­ple and par­ents with chil­dren ex­pe­ri­enc­ing se­vere al­ler­gic re­ac­tions. Now, ARS Phar­ma­ceu­ti­cals

Roche’s Genen­tech, Gilead, Sanofi and oth­er drug­mak­ers weighed in on the FDA’s re­cent draft guid­ance on re­search in­spec­tions, with the com­pa­nies call­ing for clar­i­ty and

Eyes are on CAR-T ther­a­py clin­i­cal tri­als in au­toim­mune dis­eases for po­ten­tial­ly more se­ri­ous side ef­fects, af­ter Ca­balet­ta Bio’s can­di­date was linked with a high

Plus, news about Ar­row­head, Cul­li­nan Ther­a­peu­tics, Cy­to­ki­net­ics, Zen­tal­is, In­ovio and Mind Med­i­cine: Do­mes­tic biotech M&A in Chi­na: North­east Phar­ma­ceu­ti­cal Group, a decades-old mak­er of gener­ics